Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jardiance vs Metformin in Prehypertensive Type 2 Diabetics
NCT01001962Phase 4Unknown
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jan 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of empagliflozin in hypertension (HTN), sponsored by Aristotle University of Thessaloniki. Primary endpoint: New onset of hypertension at 36 months. Status: unknown.
02
Drugs
empagliflozin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01001962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001962.